New Phase III READY-4 Data Demonstrate Long-Term Safety and Efficacy of Galderma’s RelabotulinumtoxinA (Relfydess™) October 21, 2024
TS PGECET 2024 phase 2 seat allotment result released at pgecetadm.tsche.ac.in: Direct link to check here October 9, 2024
Edison Investment Research publishes Executive interview with Sten R. Sörensen, CEO, Cereno Scientific, on positive topline Phase IIa results October 7, 2024
GE HealthCare Announces Phase I Results for a First-of-its-Kind Macrocyclic Manganese-Based MRI Contrast Agent October 7, 2024
Phase Holographic Imaging PHI AB receives approx. SEK 5.2 million through warrant exercise October 4, 2024
TS ICET 2024 special phase allotment result released at tgicet.nic.in: Direct link to check here October 4, 2024
TS LAWCET Phase II Seat Allotment Results Out at lawcetadm.tsche.ac.in: Check Direct Links Here October 3, 2024
BioStock has published an article and interview with CEO Sten R. Sörensen on the positive topline results from Cereno Scientific’s Phase IIa trial on CS1 in PAH October 3, 2024
